Endocrinology
Latest News
Drug recall in U.S. causes extreme hardship for hypoparathyroid patients
Approximately 2,700 patients in the United States have been affected by the recall of Natpara.
Conference Coverage
Reward, decision-making brain regions altered in teens with obesity
CHICAGO – Degradation in these key areas was associated with higher insulin and leptin levels.
Conference Coverage
Bethesda system underpredicts malignancy in pediatric thyroid tumors
CHICAGO – Malignancy was more likely in pediatric patients, especially for indeterminate nodules.
From the Journals
Nearly one in five U.S. adolescents have prediabetes
Prediabetes is more common in male adolescents than in female adolescents in the United States.
Conference Coverage
DAPA-HF: Dapagliflozin benefits regardless of age, HF severity
PHILADELPHIA – The SGLT2 inhibitor had similar efficacy in the elderly, and across the spectrum of baseline symptom status.
Conference Coverage
Elagolix is effective second-tier treatment for endometriosis-associated dysmenorrhea
PHILADELPHIA – It has a very low adverse event profile and is well tolerated.
Conference Coverage
Findings confirm link between methimazole and risk for acute pancreatitis
CHICAGO – However, there is no evidence of a cumulative dose effect.
Conference Coverage
DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics
PHILADELPHIA –
News from the FDA/CDC
FDA panel supports Vascepa expanded indication for CVD reduction
Icosapent ethyl (Vascepa), purified eicosapentaenoic acid, got unanimous support from an FDA panel for a new indication of reducing CVD events.
Conference Coverage
New model for CKD risk draws on clinical, demographic factors
The equation has demonstrated high discrimination and variable calibration across a range of populations.
Latest News
Levothyroxine dose for checkpoint inhibitor toxicity may be too high
CHICAGO – Dosing need not be automatically boosted when starting checkpoint inhibitor therapy.